Engineering a Spine Fusion Stimulator for Reliable Post-Surgical Bone Healing

End-to-end development and manufacturing of a clinically aligned stimulation system designed to enhance fusion outcomes with high safety and usability.
USA | Orthopedics & Spine Care
Therapeutic Device

Client Overview

  • Geography: USA
  • Market Segment: Orthopedics | Spine Care
  • Engagement Model: End-to-End Design, Manufacturing & Regulatory Support

Business Objective

A US-based medical device company focused on advancing non-invasive adjunct therapies to improve spinal fusion success rates.

Design, engineer, verify, and mass manufacture a Class III stimulation system delivering precise therapeutic dose with high usability and safety, along with CDSCO licensing and FDA 510(k) dossier support.

Our Solution

System Architecture & Device Functionality

  • Clinically aligned stimulation parameters tuned for effective bone growth support
  • Fixed-dose, microprocessor-controlled therapy delivery ensuring consistency
  • Simplified single-button interface minimizing patient use variability

Electronics & Product Engineering

  • Embedded control system for precise dose regulation and repeatability
  • Safety-driven circuit design aligned to essential performance requirements
  • Optimized power management for reliable long-duration therapy cycles

Mechanical & Industrial Design

  • Robust enclosure design supporting daily use in home-care settings
  • Human factors engineering to reduce user error and improve adherence

Design for Manufacturability (DFM) & Pilot Production

  • Design optimization for scalable production and cost efficiency
  • Component standardization to ensure supply chain reliability
  • Pilot builds to validate assembly processes and device performance
  • Documentation aligned with DMR/DHR for commercial manufacturing

Regulatory & Compliance

  • Parallel regulatory pathway development for US and India markets
  • CDSCO test licensing and manufacturing approval support
  • Compliance aligned with Class III device safety and performance standards

Results & Business Impact

  • Accelerated path to market through parallel regulatory and manufacturing readiness tracks
  • Reduced transition time from engineering to commercialization
  • Scalable manufacturing foundation enabling future volume ramp-up

Accelerate therapeutic device commercialization with a design-led, regulatory-integrated approach.

Ask Sygma AI

AI-Powered Assistant

SJ Assistant